ALC 74.97 ▼ -0.31% Live Trading Data - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Alcon Inc.

    NYSE: ALC · Real-Time Price · USD
    74.97
    -0.23 (-0.31%)
    At close: Sep 24, 2025, 3:59 PM
    75.04
    0.09%
    After-hours: Sep 24, 2025, 06:58 PM EDT
    -0.31%
    Bid 74.8
    Market Cap 37.07B
    Revenue (ttm) 10.03B
    Net Income (ttm) 1.07B
    EPS (ttm) 2.09
    PE Ratio (ttm) 35.87
    Forward PE 21.92
    Analyst Buy
    Dividends $0.6
    Ask 75.8
    Volume 3,073,612
    Avg. Volume (20D) 1,921,266
    Open 75.00
    Previous Close 75.20
    Day's Range 74.77 - 75.35
    52-Week Range 74.77 - 100.71
    Beta 0.69
    Ex-Dividend Date May 13, 2025

    About ALC

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol ALC
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for ALC stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Next Earnings Release

    Alcon Inc. is scheduled to release its earnings on Nov 11, 2025, after market closes.
    Analysts project revenue of ... Unlock content with Pro Subscription
    1 month ago
    -2.3%
    Alcon shares are trading lower after Stifel cut it... Unlock content with Pro Subscription
    1 month ago
    -10.08%
    Alcon shares are trading lower after the company cut its FY25 sales guidance.
    news image

    2 days ago · businesswire.com

    STAAR Surgical Announces Expiration of “Window Shop” Period; No Competing Acquisition Proposals Received

    LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, toda...

    news image

    3 days ago · businesswire.com

    Yunqi Capital, 5.1% Holder and One of STAAR Surgical Company's Largest Shareholders, Announces Intention to Vote Against the Proposed Sale to Alcon

    HONG KONG--(BUSINESS WIRE)--Yunqi Capital Limited (together with its affiliates and the funds it advises, “Yunqi Capital”), an investment management firm and 5.1% shareholder of STAAR Surgical Company...

    news image

    5 days ago · zacks.com

    Is it a Prudent Move to Retain ALC Stock in Your Portfolio Now?

    Alcon sees growth from surgical innovation and vision care products, but faces macro pressures and fierce competition.

    news image

    6 days ago · zacks.com

    Alcon's UNITY VCS Shows Superior Efficiency in Studies, Stock Up

    ALC's UNITY VCS shows faster, more efficient cataract and vitreoretinal surgery results, lifting shares after study presentations.

    news image

    1 week ago · businesswire.com

    STAAR Surgical Board of Directors Unanimously Believes Alcon Merger Maximizes Value for STAAR Stockholders

    LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, toda...

    news image

    1 week ago · businesswire.com

    Alcon Announces New Time and Motion Study Results Supporting Superior Efficiency* for Cataract and Vitreoretinal Surgery with UNITY VCS

    GENEVA--(BUSINESS WIRE)--Alcon Announces New Time and Motion Study Results Supporting Superior Efficiency* for Cataract and Vitreoretinal Surgery with UNITY VCS.

    news image

    4 weeks ago · businesswire.com

    Alcon to Present at 2025 Baird Global Healthcare Conference

    GENEVA--(BUSINESS WIRE)--Alcon to Present at 2025 Baird Global Healthcare Conference.

    news image

    1 month ago · zacks.com

    Alcon's Q2 Earnings Beat Estimates, Revenues Miss, Stock Plunges

    ALC's Q2 earnings top estimates but revenues fall short, sending shares down more than 10% as margins tightened and 2025 sales outlook narrowed.

    news image

    1 month ago · benzinga.com

    These Analysts Slash Their Forecasts On Alcon After Q2 Earnings

    Alcon Inc ALC posted better-than-expected earnings for the second quarter and cut its 2025 outlook late on Tuesday, citing increased tariff impact.

    news image

    1 month ago · seekingalpha.com

    Alcon Inc. (ALC) Q2 2025 Earnings Call Transcript

    Alcon Inc. (NYSE:ALC ) Q2 2025 Earnings Conference Call August 20, 2025 8:00 AM ET Call Participants Daniel Cravens - Vice President of Investor Relations David J. Endicott - CEO & Director Timothy C.

    Add to Watchlist